Search Page

1

Recent advances in inhibitors of sirtuin1/2: an update and perspective.

Zhou Z, Ma T, Zhu Q, Xu Y, Zha X. Zhou Z, et al. Among authors: Zha X. Future Med Chem. 2018 Apr 1;10(8):907-934. doi: 10.4155/fmc-2017-0207. Epub 2018 Apr 12. Future Med Chem. 2018. PMID: 29642711 Review.

Cite

Share

2

Novel Opioid Receptor Agonists with Reduced Morphine-like Side Effects.

Zhu L, Cui Z, Zhu Q, Zha X, Xu Y. Zhu L, et al. Among authors: Zha X. Mini Rev Med Chem. 2018;18(19):1603-1610. doi: 10.2174/1389557518666180716124336. Mini Rev Med Chem. 2018. PMID: 30009707 Review.

Cite

Share

3

Efficacy of two-weekly nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for breast cancer.

Xie F, Chen R, Zhang L, Yin Z, Zhu Q, You S, Jiang C, Li Y, Li S, Zha X, Wang J. Xie F, et al. Among authors: Zha X. Nanomedicine (Lond). 2019 Jun;14(12):1595-1603. doi: 10.2217/nnm-2018-0485. Epub 2019 Apr 12. Nanomedicine (Lond). 2019. PMID: 30977429

Cite

Share

4

Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease.

Huimin C, Ying C, Changying X, Xiaoming Z, Yan Z, Qingting W, Haoyang M, Lina Z, Ming Z, Guang Y, Xiaolin L, Purrunsing Y, Ningning W. Huimin C, et al. Among authors: Xiaoming Z. Horm Metab Res. 2018 Oct;50(10):761-767. doi: 10.1055/a-0723-2807. Epub 2018 Sep 17. Horm Metab Res. 2018. PMID: 30223287

Cite

Share

5

Inhibitors of Mutant Isocitrate Dehydrogenases 1 and 2 (mIDH1/2): An Update and Perspective.

Ma T, Zou F, Pusch S, Xu Y, von Deimling A, Zha X. Ma T, et al. Among authors: Zha X. J Med Chem. 2018 Oct 25;61(20):8981-9003. doi: 10.1021/acs.jmedchem.8b00159. Epub 2018 Jun 18. J Med Chem. 2018. PMID: 29847930 Review.

Cite

Share

6

AMP-activated protein kinase and energy balance in breast cancer.

Zhao H, Orhan YC, Zha X, Esencan E, Chatterton RT, Bulun SE. Zhao H, et al. Among authors: Zha X. Am J Transl Res. 2017 Feb 15;9(2):197-213. eCollection 2017. Am J Transl Res. 2017. PMID: 28337254 Free PMC article. Review.

Cite

Share

7

Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.

Xi J, Xu S, Zhang L, Bi X, Ren Y, Liu YC, Gu Y, Xu Y, Lan F, Zha X. Xi J, et al. Among authors: Zha X. Bioorg Chem. 2018 Aug;78:7-16. doi: 10.1016/j.bioorg.2018.02.016. Epub 2018 Feb 16. Bioorg Chem. 2018. PMID: 29524666

Cite

Share

8

Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia.

Xu S, Zhou C, Liu R, Zhu Q, Xu Y, Lan F, Zha X. Xu S, et al. Among authors: Zha X. Bioorg Med Chem. 2018 Sep 15;26(17):4871-4880. doi: 10.1016/j.bmc.2018.08.026. Epub 2018 Aug 22. Bioorg Med Chem. 2018. PMID: 30153955

Cite

Share

9

Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening.

Zou F, Pusch S, Hua J, Ma T, Yang L, Zhu Q, Xu Y, Gu Y, von Deimling A, Zha X. Zou F, et al. Among authors: Zha X. Bioorg Med Chem Lett. 2018 Feb 1;28(3):388-393. doi: 10.1016/j.bmcl.2017.12.030. Epub 2017 Dec 13. Bioorg Med Chem Lett. 2018. PMID: 29290542

Cite

Share

10

Sixty-Two-Year-Old Male Suffering From Uremic Leontiasis Ossea Caused by Severe Secondary Hyperparathyroidism.

Purrunsing Y, Zhang J, Cui Y, Liu W, Xu Y, Hong X, Xing C, Zha X, Wang N. Purrunsing Y, et al. Among authors: Zha X. JBMR Plus. 2018 Mar 30;2(4):240-245. doi: 10.1002/jbm4.10038. eCollection 2018 Jul. JBMR Plus. 2018. PMID: 30283905 Free PMC article.

Cite

Share